Neural precursor cells (NPCs) populate the embryonic ventricular zone and persist in the subependymal zone of the adult brain. We hypothesized that hereditary and/or acquired mutations in apoptosis-associated genes, such as p53 and caspases, may protect NPCs from DNA damage-induced death and predispose them to subsequent neoplastic transformation. To test this hypothesis, we exposed NPCs from wild-type and targeted gene-disrupted mouse embryos (p53, caspase-9, caspase-3, and bax mutants) to ethyl-nitrosourea (ENU), a known DNA mutagen and neural carcinogen, and measured NPC viability. We found that ENU produced caspase-3 activation and apoptotic NPC death 6 ± 24 h after administration both in vivo and in vitro. This eect was critically dependent on p53 and caspase-9 expression. The long-term eect of intrauterine ENU exposure was examined in control and p53-de®cient mice. High grade glial tumors were found in 60% of p53 7/7 young adult mice exposed to ENU on gestational day 12.5 but not in p53 +/7 or p53 +/+ littermates or in untreated p53-de®cient mice. All the tumors were located supratentorially and possessed strong immunoreactivity for glial ®brillary acidic protein and the anti-apoptotic molecule Bcl-X L . These results suggest that intrauterine exposure of NPCs to certain DNA damaging agents may synergistically interact with speci®c genetic abnormalities (e.g. p53 de®ciency) to produce glial neoplasms in the adult brain. Oncogene (2001) 20, 8281 ± 8286.
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Keywords: p53; astrocytoma; Bcl-X L ; programmed cell death Glioblastoma multiforme (GBM) is the most common malignant brain tumor in adults. Despite advances in microsurgical techniques, radiation therapy delivery, chemotherapeutic regimens, and characterization of genetic abnormalities associated with such tumors, median survival for patients with GBMs is less than 2 years (Stiles, 1998) . GBMs may arise either`de novo' or from malignant progression of lower grade astrocytic neoplasms, so called`secondary' GBMs (Kleihues et al., 2000) . p53 mutations are commonly found in GBMs, particularly in`secondary' GBMs where approximately 65% possess p53 mutations (Watanabe et al., 1997) . It has been proposed that p53 dysfunction is an early event in glial tumorigenesis and that additional genetic alterations must occur for full expression of the malignant glial phenotype. An emerging concept is that brain tumors arise from mutated NPCs which in the embryonic brain populate the ventricular zone and consist of self-renewing pluripotent neural stem cells and lineage-restricted progenitor cells Rao, 1999) . These cells are mitotically active and persist in the subependymal region of the adult brain (Doetsch et al., 1999; Johansson et al., 1999; McKay, 1997) .
Apoptotic death is important for normal nervous system development and the signi®cance of NPC death in this process has become increasingly recognized (Frank et al., 1998) . Targeted gene-disruptions have identi®ed Bcl-2 and caspase family members, including Bax, Bcl-X L , caspase-9, and caspase-3, as important regulators of apoptosis in the nervous system, although the signi®cance of each of these molecules is highly neural cell type and maturation speci®c (Aloyz et al., 1998; Eves et al., 1996; Johnson et al., 1999) . Our laboratory has demonstrated that DNA damage to NPCs triggers a p53-and caspase-9-dependent death pathway (D'Sa-Eipper et al., 2001) and we hypothesize that glial tumors in the adult brain arise from mutated NPCs that have escaped apoptotic deletion during development. If true, acute exposure to ENU, a known DNA mutagen and neural carcinogen, should produce NPC death and inhibition of this eect by mutations in p53 should markedly increase the frequency of brain tumor formation. To test this hypothesis, we studied the acute eect of ENU on NPC survival both in vitro and in vivo and assessed brain tumorigenesis in p53 +/+ , p53 +/7 , and p53 7/7 adult mice following a single intrauterine ENU exposure.
NPCs were isolated from the embryonic telencephalon of wild-type mice on gestational day 12 ± 13 and treated with various concentrations of ENU in vitro.
Cell viability was assessed 6 h later by¯ow cytometry using MitoTracker Red and SYTOX Green labeling as previously described . Treatment with ENU resulted in a concentrationdependent decrease in NPC viability ( Figure 1a ) and this eect was inhibited by actinomycin D (1 mg/ml), an RNA synthesis inhibitor, cycloheximide (1 mg/ml), a protein synthesis inhibitor, or the broad-spectrum caspase inhibitor Boc-Asp (OME)-Fluoro-methyl-ketone (BAF; 300 mM) (Figure 1b) . Caspase-3-like enzymatic activity was examined using an in vitrō uorogenic substrate cleavage assay (DEVD-AMC) as previously described (Zaidi et al., 2001) . ENU treatment produced a dramatic time-dependent increase in caspase-3-like enzymatic activity in wild-type NPCs (Figure 1c ). In total, these results indicate that ENU exposure produces a caspase-dependent NPC death that also requires new gene transcription and protein translation.
The in vivo eect of ENU on NPCs was examined by injecting pregnant mice intraperitoneally with ENU (25 mg/kg body weight) on gestational day 12 ± 13 and harvesting embryos 18 ± 24 h later. The ENU dose and gestational age were chosen to match those previously demonstrated to produce neural tumors in geneticallysusceptible experimental animals (Bilzer et al., 1989; Diwan and Meier, 1974; Schlegel et al., 1993) . At this gestational age, the murine telencephalon consists predominantly of nestin immunoreactive NPCs localized in the mitotically active ventricular zone. Apoptosis was assessed in control and ENU-exposed embryos with TUNEL staining and histopathological were treated for 6 h with 1 mM ENU in the presence or absence of actinomycin D (ActD, 1 mg/ml, Sigma), cycloheximide (CHX, 1 mg/ml, Sigma) or the broad-spectrum caspase inhibitor, BocAsp (OMe)-Fluoro-methyl-Ketone (BAF; 300 mM; Enzyme Systems Products, Livermore, CA, USA). Viability was assessed using MitoTracker Red and SYTOX Green labeling. Data are expressed as a percentage of the untreated cells. (c) Freshly dissociated E12 ± 13 telencephalic cells (100 000 cells) were treated with 1 mM ENU for dierent lengths of time. Caspase-3-like enzymatic activity was assayed using a previously described protocol (Armstrong et al., 1997) . Brie¯y, cells were washed once with PBS and lysed in 50 ml of buer A (10 mM HEPES, pH 7.4, 42 mM KCl, 5 mM MgCl 2 , 1 mM DTT, 0.5% CHAPS, 1 mM PMSF and 1 mg/ml leupeptin). Ac-DEVD-AMC (Biomol, Plymouth Meeting, PA, USA) at a ®nal concentration of 10 mM in 100 ml of buer B (25 mM HEPES, pH 7.4, 1 mM EDTA, 0.1% CHAPS, 10% sucrose, and 3 mM DTT) was added and incubated for 20 min at room temperature in the dark. The generation of the¯uorescence amc cleavage product was measured at excitation 360 nm, emission 460 nm, every 2 min for 2 h using a¯uorescent plate reader. Ac-DEVD-AMC cleavage activity was expressed relative to untreated controls. ENU was found to cause a signi®cant increase in caspase-3-like enzymatic activity as soon as 3 h after exposure. In all experiments, each data point represents mean+s.e.m. (n=3). *P50.05 versus untreated cells (Tukey Test) identi®cation of apoptotic nuclear morphology with bisbenzimide (Hoechst 33258) and Hematoxylin and Eosin (H&E) staining of paran-embedded sections. Activation of caspase-3 was detected with an antiserum that is speci®c for cleaved`activated' caspase-3 and does not detect caspase-3 zymogen (Srinivasan et al., 1998) . In contrast to sections of untreated embryos (Figure 2a ), H&E stained sections of ENU-exposed embryos showed numerous telencephalic cells with apoptotic histological features (Figure 2b ). ENU Figure 2 p53 or caspase-9 de®ciency protects against ENU-induced NPC apoptosis in vivo. p53 mutant mice were purchased (Taconic, Germantown, NY, USA) and caspase-9, caspase-3 and bax mutant mice have been previously described . Heterozygous mice were crossed to generate wild-type, heterozygous and homozygous gene-disrupted mice. Endogenous and disrupted genes were detected by PCR analysis of tail DNA extracts as previously described Timme and Thompson, 1994) . Pregnant mice between gestational day 12 and 13 were intraperitoneally injected with ENU (25 mg/kg body weight). Embryos were isolated 6 ± 24 h later and placed in cold Bouin's ®xative, followed by paran embedding. Activated caspase-3-like immunoreactivity was detected with an anity puri®ed rabbit polyclonal antiserum, CM1, which recognizes the p18 subunit of cleaved caspase-3 (Srinivasan et al., 1998) and was used at a dilution of 1 : 40,000. Cell nuclei were stained by incubating sections for 10 min in a 0.2 mg/ml solution of bisbenzimide (Hoechst 33258; Sigma) and visualized on a Zeiss-Axioskop microscope equipped with epi¯uorescence. Few apoptotic cells were observed in the untreated wild-type telencephalon (a). Transplacental ENU-exposure of wild-type embryos produced numerous apoptotic cells (examples indicated by arrows) within the telencephalon as evidenced by H&E staining (b). Intense activated caspase-3 immunoreactivity was detected within the telencephalon of E12-13 wild-type embryos after ENU exposure (c). In contrast, ENU exposed p53 7/7 (d) and caspase-9 7/7 (e) embryos showed no evidence of activated caspase-3-like immunoreactivity within the telencephalon. ENU exposed Bax-de®cient embryos (f) showed a similar extent of activated caspase-3-like immunoreactivity in the telencephalon as ENU treated wild-type embryos (c). Scale bar=20 mm in a and b, and 50 mm in c ± f, respectively exposure produced intense activated caspase-3-like immunoreactivity ( Figure 2c ) and frequent TUNEL reactivity (data not shown) in telencephalic NPCs.
To determine the roles of speci®c pro-apoptotic molecules in ENU-induced NPC apoptosis, we examined the eect of transplacental ENU exposure on p53 7/7 , caspase-9
, caspase-3
, bax 7/7 and wildtype E12-13 mice in vivo. In contrast to wild-type mice, p53 7/7 and caspase-9 7/7 embryos showed no evidence of caspase-3 activation or apoptosis in the telencephalon 24 h after ENU exposure (Figure 2d,e) . In some cell types, DNA damage causes a p53-dependent upregulation of bax expression that is required for cell death (Johnson et al., 1998) . ENU-induced NPC apoptosis however, was found to be independent of bax expression since Bax-de®cient telencephalic NPCs showed extensive caspase-3 activation and apoptosis 24 h after ENU exposure (Figure 2f) . A variety of studies have indicated that caspase-3 activation is required for production of an apoptotic phenotype but that it may not be necessary for death per se (D'SaEipper et al., 2001; Zheng et al., 1998) . To determine the signi®cance of caspase-3 expression in ENUinduced NPC death, we examined the eects of ENU on wild-type and caspase-3 7/7 NPCs in vivo. ENUexposed caspase-3-de®cient embryos showed no immunohistochemical evidence of NPC caspase-3 activation and apoptotic nuclear features were not observed. However, many telencephalic NPCs exhibited hyperchromatic, abnormally-shaped nuclei and cytoplasmic vacuolization identical to that we have previously observed in g-irradiated or cytosine arabinoside exposed caspase-3-de®cient NPCs (D' Sa-Eipper et al., 2001) . Such degenerating cells are only rarely observed in untreated caspase-3-de®cient embryos and likely represent cells undergoing a cytologically distinct form of cell death (Oppenheim et al., 2001) . In vitro¯ow cytometric studies have also demonstrated extensive cell death of caspase 3 7/7 NPCs following exposure to g-irradiation or cytosine arabinoside , indicating that caspase-3 de®ciency alters the phenotype of DNA-damaged NPCs but does not protect against the cytotoxic eects of DNA-damage. In total, these studies of gene-disrupted NPCs indicate that ENU, like other DNA damaging agents that we have studied (g-irradiation, cytosine arabinoside, etoposide), causes p53-and caspase-9-dependent, Baxand caspase-3-independent NPC death.
ENU has been used in a variety of paradigms to induce neural tumors including astrocytomas, oligo- Figure 3 Eects of transplacental ENU exposure on brain tumorigenesis in p53-de®cient mice. Pregnant mice between gestational day 12 and 13 were intraperitoneally injected with ENU (25 mg/kg body weight). These animals were allowed to give birth, and pups were weaned and genotyped at approximately 3 weeks. Mice were sacri®ced between 2 and 5 months of age. Bouin's ®xed brains were sequentially sectioned and examined for evidence of neoplasia by H&E staining. Immunostaining of sections with antibodies to glial ®brillary acid protein (GFAP, 1 : 1000, DAKO, Carpinteria, CA, USA), proliferating cell nuclear antigen (PCNA, 1 : 1000, Calbiochem, La Jolla, CA, USA) and Bcl-X L (1 : 50, Santa Cruz, Santa Cruz, CA, USA) were done using previously described methods (D'Sa-Eipper et al.,
2001
; Motoyama et al., 1995; Roth et al., 2000; Shindler et al., 1997) . Cell nuclei were stained by incubating sections for 10 min in a 0.2 mg/ml solution of bisbenzimide (Hoechst 33258; Sigma) and visualized on a Zeiss-Axioskop microscope equipped with epi¯uorescence. (a) H&E section of a representative brain tumor found 10 weeks after ENU exposure shows marked cellularity including mitotic ®gures (black arrow) and bizarre pleomorphic cells (white arrow). Scale bar=50 mm. (b) All tumors examined showed frequent GFAP immunoreactive cells (red). Scale bar=50 mm. (c) Immunostaining of tumor sections with antibodies to PCNA (green) and Bcl-X L (red) demonstrated colocalization of PCNA and Bcl-X L within a subpopulation of tumor cells (arrow). Scale bar=10 mm dendrogliomas, mixed glial tumors, schwannomas, meningiomas, and/or medulloblastomas depending on dose, injection schedule, age of the animal, and species susceptibility (Bilzer et al., 1989; Diwan and Meier, 1974; Druckrey et al., 1966; Schlegel et al., 1993) . Single intrauterine exposure to ENU may produce central nervous system tumors in rats (Wechsler et al., 1969) ; however, mice are relatively insensitive to this eect (Diwan and Meier, 1974; Wechsler et al., 1979) . The very low rate of brain tumors in ENU exposed mice has permitted a very sensitive analysis of the role of p53 in brain tumor formation. p53-de®cient mice show only a low incidence of brain tumors (Jacks et al., 1994) ; however, a synergistic eect between p53 de®ciency and transplacental ENU exposure has been suggested in two previous studies (Klein et al., 2000; Oda et al., 1997) .
To further de®ne the relationship between p53 function and brain tumorigenesis, we examined the eect of intrauterine exposure to ENU (25 mg/kg IP into the pregnant female on gestational day 12-13) on brain tumor formation in p53 7/7 , p53 +/7 and p53 +/+ adult mice. Mice were sacri®ced when they appeared in respiratory distress (secondary to thymic lymphomas), moribund (secondary to neurological de®cits such as seizures, paralysis and/or movement abnormalities), or at 5 months of life (at which point there were no surviving p53 7/7 mice). Untreated p53
, p53 +/7 , and p53 +/+ young adult mice (55 months old) showed no evidence of brain tumors (data not shown) consistent with several previous reports of a low incidence (51%) of brain tumor formation in p53-de®cient mice (Jacks et al., 1994; Oda et al., 1997) . One or more brain tumors were found in approximately two-thirds of the ENU-treated p53 7/7 mice; in contrast, no brain tumors were observed in ENUexposed p53 +/7 or p53 +/+ mice ( Table 1 ). The vast majority of ENU exposed p53 7/7 mice developed thymic lymphomas necessitating their sacri®ce between 2 and 5 months of life (Table 1) . Untreated p53-de®cient mice typically developed thymic lymphomas at an older age (26 ± 52 weeks) (Jacks et al., 1994) . All the brain tumors identi®ed were supratentorial and ranged in size from microscopic foci to large, grossly identi®able tumors. H&E-stained sections revealed multiple histopathological features of high-grade astrocytic neoplasms including: brisk mitotic activity, nuclear anaplasia, cellular pleomorphism, vascular proliferation, hemorrhage and/or necrosis (Figure 3a) . Immunohistochemical characterization of the tumors demonstrated extensive immunoreactivity for proliferating cell nuclear antigen (PCNA) and strong staining for glial ®brillary acidic protein (Figure 3b ) in many tumor cells. Scattered tumor cells showed nestin immunoreactivity but no immunoreactivity for neuronal nuclear antigen or microtubule-associated protein 2 was observed in any of the tumors examined (data not shown). These immunohistochemical and histopathological studies indicate that the ENU-induced brain tumors are high-grade (WHO grade III-IV) astrocytic neoplasms.
Several studies have reported that human astrocytic neoplasms commonly show evidence for expression of the anti-apoptotic molecule, Bcl-X L (Bruggers et al., 1999; Krajewski et al., 1997) . Bcl-X L expression is found in a variety of tumor cell lines and appears to correlate with chemotherapeutic resistance (Dole et al., 1994 (Dole et al., , 1995 Liu et al., 1999) . Bcl-X L expression is not found in NPCs nor is it expressed in normal astrocytes. To determine if ENU-induced astrocytic neoplasms showed evidence for Bcl-X L expression, we used an antibody that we have previously identi®ed as immunohistochemically speci®c for Bcl-X L . All of the examined brain tumors (nine of nine) showed intense Bcl-X L immunoreactivity in a signi®-cant subpopulation of neoplastic cells and dual labeling for Bcl-X L and PCNA immunoreactivity showed coexpression in many tumor cells (Figure 3c ). These immunohistochemical observations indicate that ENUinduced murine brain tumors, like human glial neoplasms, show abnormal expression of Bcl-X L , which may confer anti-apoptotic properties to the neoplastic cells.
In total, our studies suggest that glial tumorigenesis and progression may involve NPCs and several apoptosis-associated molecules. We hypothesize that similar to the p53-de®cient ENU-induced glial tumor model, human high-grade astrocytic neoplasms may arise from mutated NPCs that have escaped developmental deletion. We further propose that persistence of NPCs in the adult brain provides the necessary time for accumulation of additional genetic alterations, such as those that occur in secondary GBMs, and the development of apoptosis resistance which are required for tumor progression. p53, caspase-9 and Bcl-X L may be important regulators of this process.
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